复方远志合剂对急性支气管炎的疗效及安全性评价(1)
第1页 |
参见附件。
[摘要] 目的:观察应用复方远志合剂对急性支气管炎的疗效及安全性。方法:将100例急性支气管炎患者随机分为治疗组(50例)和对照组(50例),治疗组在支气管炎常规治疗基础上给予口服复方远志合剂治疗,疗程为1周,于治疗前后分别测定末梢血白细胞计数(WBC)及分类,部分患者做X线检查。结果:治疗组临床痊愈率和总有效率分别为80.0%和98.0%;对照组临床痊愈率和总有效率分别为60.0%和92.0%;治疗组治疗后临床痊愈率及总有效率明显优于对照组(P<0.05)。结论:复方远志合剂对急性支气管炎有明显的镇咳祛痰效果,安全性良好。
[关键词] 复方远志合剂;中药治疗;疗效评价
[中图分类号] R562.2+1[文献标识码] A[文章编号] 1673-7210(2010)02(b)-016-03
The efficacy and safety of Fufangyuanzhi Mixture for acute bronchitis
SUN Yi, CHU Fuming, CHENG Shenling, GUO Ling, HUANG Zhen
(Department of Pharmacy, Tengzhou Central People's Hospital of Shandong Province, Tengzhou 277500, China)
[Abstract] Objective: To observe the efficacy and safety of Fufangyuanzhi Mixture for acute bronchitis. Methods: 100 patients with acute bronchitis were randomly divided into treatment group (n=50) and control group (n=50) ......
您现在查看是摘要介绍页,详见PDF附件。